Top considerations for clinical trials
After the hiatus brought about by the pandemic, activity in the clinical trials sector is now growing, with a number of trials due to launch at the end of this quarter. Increasingly, participants in trials and partners in Clinical Research Organisations (CROs) are seeking assurance that a Data Protection Officer (DPO) has been appointed [...]